Clinical trial
Prospective Randomised Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of Painful Bladder Syndrome/ Interstitial Cystitis
NCT04268810 is registered in ClinicalTrials.gov with National Multiple Sclerosis Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomised Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of Painful Bladder Syndrome/ Interstitial Cystitis
- Lead sponsor
- National Multiple Sclerosis Center
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 31, 2010
- Completion date
- December 31, 2013
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
interstitial cystitis, painful bladder syndrome